Hind Almodaimegh
Overview
Explore the profile of Hind Almodaimegh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alraddadi S, Almodaimegh H, Kharbosh A, Alharbi H, Fathelrahman A, Alsheikh M, et al.
Diabetol Metab Syndr
. 2025 Jan;
17(1):41.
PMID: 39891190
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors effectively reduce LDL cholesterol and adverse cardiovascular events with a safety profile comparable to a placebo. Limited real-world data exists on their effectiveness...
2.
Al Raddadi S, Almutairi M, Alaamer K, Alsalman A, Albalawi M, Almeshary M, et al.
Drug Healthc Patient Saf
. 2024 Oct;
16:117-124.
PMID: 39372487
Background: Sacubitril/valsartan (S/V) is used in managing heart failure with reduced ejection fraction (HFrEF), reducing morbidity and mortality while improving symptoms and prognosis. This study aims to evaluate the effectiveness...
3.
Abu Esba L, Almodaimegh H, Khan M, Yousef C, Al-Abdulkarim H, Al Aklabi A, et al.
Glob J Qual Saf Healthc
. 2024 May;
7(2):88-94.
PMID: 38725883
No abstract available.
4.
Yousef C, Khan M, Almodaimegh H, Alshamrani M, Al-Foheidi M, AlAbdalkarim H, et al.
J Med Econ
. 2023 Feb;
26(1):394-402.
PMID: 36815700
Aims: This study estimated, for Saudi Arabia, the cost-efficiency of converting patients from reference Neupogen and Neulastim to one of two filgrastim biosimilars (Nivestim, Zarzio); the budget-neutral expanded access to...
5.
Alshahrani E, Aljohani R, Sahli A, Alruwaili W, Almohini I, Almodaimegh H
Cureus
. 2022 Jan;
13(12):e20189.
PMID: 35004012
Background and objective Hypertension (HTN) is a common disease among patients who visit primary healthcare clinics. Uncontrolled HTN is associated with increased morbidity and mortality; therefore, awareness of its risk...
6.
Alhabardi S, Almodaimegh H, Alammari M
Sci Rep
. 2021 Apr;
11(1):8760.
PMID: 33888828
Hydromorphone is a semi-synthetic opioid that acts mainly on the μ-opioid receptor. Hydromorphone has a fast onset of action, usually within 5 min, and its effectiveness peaks at approximately 20 ...
7.
Alsuhebany N, Alfehaid L, Almodaimegh H, Albekairy A, Alharbi S
SAGE Open Nurs
. 2021 Jan;
5:2377960819889769.
PMID: 33415259
Clinical pharmacists are responsible for guiding pharmacotherapy and ensuring medication safety along with other health-care providers. This study highlighted barriers that physicians and nurses encounter when interacting with clinical pharmacists....
8.
AlSumih N, Alqahtani R, Almutairi F, Faraj R, Alsubeai T, Alghanim A, et al.
J Saudi Heart Assoc
. 2020 Nov;
32(1):46-51.
PMID: 33154891
Background: Heart failure (HF) is a chronic disease affecting patients' quality of life (QoL) and may cause depression. Recent studies reported that the prevalence of depression in patients with HF...
9.
Alrashidi T, Alregaibah R, Alshamrani K, Alhammad A, Alyami R, Almadhi M, et al.
Cureus
. 2020 Oct;
12(9):e10401.
PMID: 33062520
Background Hyperkalemia is a serious life-threatening condition that leads to significant morbidity and mortality. Objectives The aim of this study is to investigate the association between the duration and outcomes...
10.
Hussain A, Mustafa N, Al Ali R, Almodaimegh H
Eur Heart J Suppl
. 2020 Apr;
16(Suppl B):B52-B54.
PMID: 32288642
Adult Cardiac Critical Cardiac Care division at the King Abdulaziz Cardiac Center - Riyadh, Saudi Arabia, was created in 2011 to address the critical care needs of cardiac surgery and...